Malignant pleural mesothelioma in Singapore

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 5, 2011, Pages 1155-1159

  Yip, C S P ^a   Koong, H N ^a   Loo, C M ^b   Fong, K W ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Asia; Malignant pleural mesothelioma; Outcomes

Indexed keywords

EID: 84857954216     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Antman K, Shemin R, Ryan L, et al (1988). Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol, 6, 147-53.
2. Ascoli V, Scalzo CC, Facciolo F, et al (1996). Malignant mesothelioma in Rome, Italy 1980-1995. A retrospective study of 79 patients. Tumori, 82, 526-32.
3. Balduyck B, Trousse D, Nakas A, et al (2010). Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile? Ann Thorac Surg, 89, 907-11.
4. Chan K, Tan KL, Lee HS, et al (2003). Malignant mesothelioma: experience at the Singapore General Hospital. Ann Acad Med Singapore, 32, 388-91.
5. Curran D, Sahmoud T, Therasse P, et al (1998). Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol, 16, 145-52.
6. de Perrot M, Feld R, Cho BC, et al (2009). Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol, 27, 1413-8.
7. Edwards JG, Abrams KR, Leverment JN, et al (2000). Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax, 55, 731-5.
8. Edwards JG, Swinson DE, Jones JL, et al (2006). EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma. Lung Cancer, 54, 399-407.
9. Iyoda A, Yusa T, Kadoyama C, et al (2008). Diffuse malignant pleural mesothelioma: a multi-institutional clinicopathological study. Surg Today, 38, 993-8.
10. Krug LM, Pass HI, Rusch VW, et al (2009). Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol, 27, 3007-13.
11. Rice DC, Stevens CW, Correa AM, et al (2007). Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg, 84, 1685-92; discussion 1692-3.
12. Schipper PH, Nichols FC, Thomse KM, et al (2008). Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg, 85, 257-64; discussion 264.
13. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al (1999). Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg, 117, 54-63; discussion 63-5.
14. Sugarbaker, D. J., J. P. Garcia, W. G. Richards, et al (1996). Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg, 224, 288-94; discussion 294-6.
15. Yates DH, Corrin B, Stidolph PN, et al (1997). Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax, 52, 507-12.